BREAKING: Thousands of UK claimants have initiated a major legal battle against Johnson & Johnson over allegations linking its talcum powder to cancer diagnoses. Lawyers announced...
Johnson & Johnson (NYSE: JNJ) has announced a significant advancement in cancer treatment with the successful results of its late-stage trial for Tecvayli (teclistamab). The study...
Johnson & Johnson is set to release its earnings report for the third quarter of 2023 on October 24, 2023. This report will provide critical insights...
Wall Street experienced significant declines on September 29, 2023, following U.S. President Donald Trump‘s announcement of potential new tariffs targeting China. Trump characterized China as having...
Wall Street’s major indices experienced mixed outcomes on Friday as investors continued to assess the implications of the ongoing U.S. government shutdown, now in its third...
A jury has ordered Johnson & Johnson to pay over US$42 million to a Massachusetts man, Paul Lovell, who claims that decades of using the company’s...
